These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 465131)

  • 1. [Studies on blood coagulation systems during defibrinogenation therapy with batroxobin (Bothrops atrox venom) (author's transl)].
    Ishimaru S; Konishi M; Furukawa K; Takahashi M; Fujimaki M
    Rinsho Ketsueki; 1979 May; 20(5):500-9. PubMed ID: 465131
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of herpes zoster with hemocoagulase (Bothrops Jararaca venom)].
    De Candia O; Baghiris D
    Clin Ter; 1979 Jun; 89(6):589-93. PubMed ID: 397028
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441
    [No Abstract]   [Full Text] [Related]  

  • 4. [Defibrination-therapy using a thrombin-like snake venom enzyme (Defibrase) Blood-coagulation physiological studies and clinical experiences].
    Martin M; Engelken HJ; Tambert F; Martin U; Hirdes E; Auel H
    Vasa Suppl; 1976; 5():1-39. PubMed ID: 1070197
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodilution combined with defibrinogenation.
    Böhme H; Everts B
    Bibl Haematol; 1981; (47):165-72. PubMed ID: 7039611
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic lowering of fibrinogen levels].
    Ernst E
    MMW Munch Med Wochenschr; 1983 May; 125(21):83-4. PubMed ID: 6410202
    [No Abstract]   [Full Text] [Related]  

  • 7. Derivatives of fibrinogen and fibrin during defibrase therapy. Separation of high and low molecular weight derivatives of fibrinogen and fibrin by agarose gel filtration.
    Asbeck F; Lechler E; Martin M; van de Loo J
    Haemostasis; 1974; 3(5-6):340-7. PubMed ID: 4468232
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modification of the toxicity of Bothrops atrox poison by interventions in the coagulation and kallikrein system of prey].
    Meier J; Stocker K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):877-82. PubMed ID: 6083965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action on "in vitro" coagulation of Bothrops jararaca and Bothrops atrox snake venoms (reptilase)].
    SANCHEZ FAYOS J; OUTEIRINO J; PANIAGUA G; SERRANO J; MARTINEZ MT
    Rev Clin Esp; 1960 May; 77():215-25. PubMed ID: 14441323
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of snake venom, Defibrase, on haemostasis (author's transl)].
    Donner L; Klener P; Setková O
    Sb Lek; 1980; 82(7):203-11. PubMed ID: 6996078
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of defibrinogenation with batroxobin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kato H; Kondo M
    Thromb Res; 1983 Sep; 31(5):729-35. PubMed ID: 6359574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops atrox. On the primary structure of fragment E.
    Egberg N
    Acta Physiol Scand Suppl; 1973; 400():1-47. PubMed ID: 4599946
    [No Abstract]   [Full Text] [Related]  

  • 13. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical pharmacology of the hemocoagulase isolated from Bothrops jararaca venom].
    Pupita F; Di Placido V; Zini R; Pupita P
    Clin Ter; 1982 Jun; 101(6):629-38. PubMed ID: 6751665
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reduction of hyperfibrinemia in the nephrotic syndrome using defibrase].
    Salvadori JM; Follana R; Olmer M
    J Urol Nephrol (Paris); 1975 Sep; 81(9):691-6. PubMed ID: 1214313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of anticoagulation methods available for extracorporeal circulation in the dog].
    Legendre L; Guidoin R; Martin L; Blais P; Marois M; Roy J; Awad J
    Union Med Can; 1980 Mar; 109(3):387-96. PubMed ID: 6990575
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic defibrinogenation in peripheral vascular disease.
    Ernst E
    Int Angiol; 1985; 4(3):373-7. PubMed ID: 3913715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vein surgery during defibrinogenation.
    Browse NL; Clemenson G
    Br J Surg; 1978 Jul; 65(7):452-5. PubMed ID: 149578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approach to thrombolytic therapy: the use of Defibrase in connection with streptokinase.
    Latallo ZS; Lopaciuk S
    Thromb Diath Haemorrh Suppl; 1973; 56():253-64. PubMed ID: 4617332
    [No Abstract]   [Full Text] [Related]  

  • 20. Laboratory control of SK therapy.
    Conard J; Samama M
    Thromb Diath Haemorrh Suppl; 1973; 56():191-8. PubMed ID: 4805495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.